(Kearney, NE; August 9, 2011) – SCORR Marketing, a strategic marketing agency focused on drug development services, has been selected by CRI Worldwide/Lifetree Clinical Research as their agency of record. Under this partnership, SCORR Marketing will bring CRI Worldwide/Lifetree together, under one name, and develop the new company identity and brand and manage the company’s marketing components to better demonstrate and position CRI Worldwide/Lifetree as a front-runner within the life sciences industry. SCORR Marketing will also assist with communicating the companies’ combined advantages in human abuse liability and pain disorders, a significant database of patient populations and its Six Sigma Total Quality Assurance Program.
“We selected SCORR Marketing as our agency of record due to the organization’s high caliber of leadership and proven track record within the drug development and life sciences industry,” stated CEO of CRI Worldwide Jeff Kinell. “SCORR Marketing has an extensive portfolio of experience within this industry and we are thrilled to be partnering with them.”
In a recent acquisition, CRI Worldwide purchased Lifetree Clinical Research®, a Specialized Research Organization (SRO) that provides its multi-therapeutic Clinical Trials Management (CTM) and site expertise to Phase I-III clinical trials. Together, the combined organizations enrich the early stage clinical research landscape for their clients, enabling them to tap into CRI’s leadership in psychiatry and expertise in complex studies, as well as Lifetree’s widely recognized expertise in pain management and human abuse liability studies.
As a clinical research provider with more than 25 years of expertise, CRI Worldwide/Lifetree is a leader focused on inpatient and outpatient Phase I-IV trials and providing sponsors with innovative solutions, quality participants and clean data. Together, the two organizations offer a broad range of services to meet the specific requirements of clinical research development programs according to the standards of Good Clinical Practice (GCP) and ICH guidelines. From patient screening and client consultation to its total quality assurance program, attention to detail and quality are primary goals for this organization.
“We are proud to have been named ‘Agency of Record’ for the entire CRI Worldwide organization,” stated SCORR Marketing President Cinda Orr. “We look forward to a successful partnership and to grow their marketing tactics and work with them on new company initiatives.”
SCORR Marketing is a full-service marketing and public relations firm offering complete strategic communications programs to clients in a wide variety of markets and industries. For more information or to view samples of their work, visit online at www.scorrmarketing.com or call 308.237.5567.
About SCORR Marketing
SCORR collaborates with energetic companies to develop “next-phase growth strategies” and utilizes a disciplined approach to marketing plans that ensures solid incremental growth year after year, creating tangible results. SCORR’s team includes dedicated talent with worldwide experience in market development, public relations and communications, customer retention and development, corporate identity/branding, broadcast and print advertising, tradeshow/event planning and promotion, and website development and hosting services. SCORR Marketing has offices in Seattle, Philadelphia and Omaha with headquarters in Kearney, Nebraska. Connect with SCORR Marketing on Facebook, LinkedIn and Twitter.
About CRI Worldwide, LLC
CRI Worldwide is a leader in clinical research with specific expertise in psychiatry, pediatrics pain and neurology, and human abuse liability. CRI specializes in assisting sponsors in the most complex of clinical trials by providing the highest quality services for patients and timely results to sponsors. Operating from facilities in Philadelphia, New Jersey, and Salt Lake City, CRI conducts inpatient and outpatient clinical research trials in patients and healthy volunteers. CRI works with sponsors to assist them in the design and successful execution of drug development plans that expedite the successful transition to Phase II proof-of-concept. For additional information about CRI, visit the company’s website at www.criww.com.
About Lifetree Clinical Research, LC
Located in Salt Lake City, Utah, and founded in 2003, Lifetree offers multi-therapeutic Clinical Trials Management site expertise in Phase I-IV clinical trials in its state-of-the-art 35,000-square-foot, 60-bed research facility. As a leader in Early Stage Research (Phase I-IV), the Lifetree clinical team specializes in Human Abuse Liability, Analgesia Pain Model Development, Sleep Medicine and Addiction. Lifetree’s facility includes an onsite operating room and pharmacy capable of handling all scheduled (I-IV) drugs. Lifetree clinical services include advanced expertise in first-in-human/MTD, bioavailability and bioequivalence, PK/PD /proof-of-concept, pain model development and cerebral fluid sampling. For additional information about Lifetree, visit the company’s website at www.lifetreeresearch.com.
